“…Covered stent occlusion was found in one case at 16 months and the patient refused a reintervention because his upper limb ischemia was tolerable. 9 In addition, instent thrombosis requiring a reintervention at 1.5 months was noted by Archie et al 7 In general, based on our experience, despite that covered stent occlusions after endovascular treatment for ISAAs are not that uncommon, most patients could tolerate the ischemia with conservative treatment and reinterventions are not always necessary whether the occlusions occur in the short or long term.…”
Section: Discussionmentioning
confidence: 63%
“…Only several cases with the follow-up period longer than 36 months have been reported in isolated small case series. 7,9 A larger cohort with long-term follow-up remains scarce. To the best of our knowledge, Archie et al reported the longest follow-up period in the published data of 60 months in one patient after covered stent exclusion of an ISAA caused by arterial thoracic outlet syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…3 However, previous reports regarding endovascular treatment for ISAAs were extremely limited compared to other peripheral aneurysms such as femoral and popliteal artery aneurysms, [4][5][6] and most of the literature are case reports with a small sample size less than 10. [7][8][9][10][11][12][13][14] Apart from the rarity of ISAAs, another factor contributing to the present situation might be that ISAAs possibly involving the vertebral and right carotid arteries make endovascular interventions more sophisticated and challenging than aneurysms located in the lower limbs. No single-center series to date has specifically summarized and assessed endovascular techniques for the exclusion of ISAAs.…”
Objectives The aim of the present study was to review our institutional experience of endovascular treatment for isolated subclavian artery aneurysms and evaluate the long-term outcomes. Methods A retrospective review of all patients with isolated subclavian artery aneurysms who underwent endovascular treatment between March 2008 and March 2020 was performed. The demographics, aneurysmal characteristics, treatment strategies, and in-hospital and follow-up outcomes were recorded and then analyzed. Results From March 2008 to March 2020, 35 isolated subclavian artery aneurysms were endovascularly treated at our institution. Atherosclerosis was the most common cause of aneurysms in this series. Most aneurysms were intrathoracic (91.4%) and located at the right side (77.1%). There were 26 true aneurysms, seven pseudoaneurysms, and two ruptured isolated subclavian artery aneurysms. Five types of endovascular strategies were performed. Covered stent placement across the aneurysm was the most (54.3%) commonly used method. Technical success was achieved in all patients. The median postoperative in-hospital stay was 4.0 days (range, 1–15 days). One patient died after discharge but within 30 days of surgery due to myocardial infarction. The median follow-up time was 62.0 months (range, 3–132 months). No death, stroke, stent fractures, or severe upper limb ischemia developed during the follow-up period. The cumulative survival rate at five years was 97.1%. The overall complication rate was 25.7% and one-third of complications (8.6%) required reinterventions. Conclusions Endovascular treatment for isolated subclavian artery aneurysms is safe, effective and technically achievable in most patients. Short- and long-term outcomes are promising. Reasonable and flexible use of covered stents can also get satisfactory outcomes in some complicated lesions such as isolated subclavian artery aneurysms located at the origin of the right subclavian artery, avoiding the huge surgical trauma caused by conventional open repair.
“…Covered stent occlusion was found in one case at 16 months and the patient refused a reintervention because his upper limb ischemia was tolerable. 9 In addition, instent thrombosis requiring a reintervention at 1.5 months was noted by Archie et al 7 In general, based on our experience, despite that covered stent occlusions after endovascular treatment for ISAAs are not that uncommon, most patients could tolerate the ischemia with conservative treatment and reinterventions are not always necessary whether the occlusions occur in the short or long term.…”
Section: Discussionmentioning
confidence: 63%
“…Only several cases with the follow-up period longer than 36 months have been reported in isolated small case series. 7,9 A larger cohort with long-term follow-up remains scarce. To the best of our knowledge, Archie et al reported the longest follow-up period in the published data of 60 months in one patient after covered stent exclusion of an ISAA caused by arterial thoracic outlet syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…3 However, previous reports regarding endovascular treatment for ISAAs were extremely limited compared to other peripheral aneurysms such as femoral and popliteal artery aneurysms, [4][5][6] and most of the literature are case reports with a small sample size less than 10. [7][8][9][10][11][12][13][14] Apart from the rarity of ISAAs, another factor contributing to the present situation might be that ISAAs possibly involving the vertebral and right carotid arteries make endovascular interventions more sophisticated and challenging than aneurysms located in the lower limbs. No single-center series to date has specifically summarized and assessed endovascular techniques for the exclusion of ISAAs.…”
Objectives The aim of the present study was to review our institutional experience of endovascular treatment for isolated subclavian artery aneurysms and evaluate the long-term outcomes. Methods A retrospective review of all patients with isolated subclavian artery aneurysms who underwent endovascular treatment between March 2008 and March 2020 was performed. The demographics, aneurysmal characteristics, treatment strategies, and in-hospital and follow-up outcomes were recorded and then analyzed. Results From March 2008 to March 2020, 35 isolated subclavian artery aneurysms were endovascularly treated at our institution. Atherosclerosis was the most common cause of aneurysms in this series. Most aneurysms were intrathoracic (91.4%) and located at the right side (77.1%). There were 26 true aneurysms, seven pseudoaneurysms, and two ruptured isolated subclavian artery aneurysms. Five types of endovascular strategies were performed. Covered stent placement across the aneurysm was the most (54.3%) commonly used method. Technical success was achieved in all patients. The median postoperative in-hospital stay was 4.0 days (range, 1–15 days). One patient died after discharge but within 30 days of surgery due to myocardial infarction. The median follow-up time was 62.0 months (range, 3–132 months). No death, stroke, stent fractures, or severe upper limb ischemia developed during the follow-up period. The cumulative survival rate at five years was 97.1%. The overall complication rate was 25.7% and one-third of complications (8.6%) required reinterventions. Conclusions Endovascular treatment for isolated subclavian artery aneurysms is safe, effective and technically achievable in most patients. Short- and long-term outcomes are promising. Reasonable and flexible use of covered stents can also get satisfactory outcomes in some complicated lesions such as isolated subclavian artery aneurysms located at the origin of the right subclavian artery, avoiding the huge surgical trauma caused by conventional open repair.
“…Endovascular repair of SAAs is case-dependent. In some complex cases, the neck of the aneurysm is close to the proximal end of the subclavian artery, and a stent graft can be implanted using the simultaneous kissing stent technique to maintain the blood flow of the right subclavian and carotid arteries and to prevent a type 1 endoleak ( 10 ). Furthermore, in cases where the SAA is located in the arterial branches, a combination of stent graft and coil embolization has been applied for endovascular treatment ( 5 ).…”
Section: Discussionmentioning
confidence: 99%
“…Most cases are treated by open surgery (2,3). With advances in interventional techniques, endovascular repair has been suggested as a less invasive alternative to surgery (4)(5)(6)(7)(8)(9)(10). However, technical and anatomical considerations complicate the treatment of SAAs and pose some challenges.…”
BackgroundGiant true subclavian artery aneurysms (SAAs) (>5 cm) are rare. Technical and anatomical considerations complicate the endovascular treatment of SAAs and pose some challenges. Here, we present a giant right SAA that was successfully excluded using stent grafts with the pull-through technique after two interventional steps and discuss the pull-through technique details as well as the lessons to be learned from this case.MethodsA 50-year-old man presented at our department complaining of dyspnea and hoarseness. Computed tomography angiography (CTA) showed a giant right SAA with partial intraluminal thrombus and severe angulated aneurysm necks originating from the proximal right subclavian artery, approximately 70 × 71 mm in size.OutcomesAn 8 × 100-mm Gore Viabahn was selected to exclude the SAA. A decision was made to stabilize the wire tension using the pull-through technique. Final angiography showed that the SAA was essentially excluded, and slight endoleak was observed. At 6 months, imaging showed that the aneurysm was not obviously shrinking, there was still an endoleak and stent graft dislodgement was observed. Angiography confirmed a type Ia endoleak, which was managed by the placement of a 10 × 50-mm Gore Viabahn, again with the assistance of the pull-through technique. At the 25-month follow-up, CTA showed that the SAA was satisfactorily excluded, with no endoleak, and the SAA was reduced in size.ConclusionsEndovascular treatment of SAAs is a safe, reliable and minimally invasive approach. The pull-through technique may improve wire tension and device stabilization. Additionally, size selection and positioning should be reappraised under a severely angulated aneurysm neck.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.